Shenzhen Beacon Display Technology Co., Ltd. has successfully passed a four-day U.S. FDA on-site inspection on May 22, 2025, marking its second successful FDA audit since 2019.

As one of the world’s most rigorous regulatory reviews, FDA inspection is recognized as a gold standard in the medical device industry, symbolizing that Beacon Display’s quality management system meets international standards for safety, reliability, and effectiveness.

Committed to the philosophy of “Meticulous Design, Intelligent Manufacturing,” Beacon Display continuously delivers high-quality medical display and human–machine interface solutions to customers worldwide.

Looking ahead, the company will keep increasing R&D and innovation investment, introducing more advanced technologies and products to serve the global healthcare market, and further strengthen its leadership in medical display solutions.